.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Deloitte
Queensland Health
Cerilliant
US Department of Justice
QuintilesIMS
Mallinckrodt
Fuji
Farmers Insurance
Express Scripts

Generated: July 28, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 205120

« Back to Dashboard
NDA 205120 describes BUTALBITAL AND ACETAMINOPHEN, which is a drug marketed by Cnty Line Pharms, Tedor Pharma Inc, Watson Labs, Nexgen Pharma, Halsey, Larken Labs Inc, and Mikart Inc, and is included in seven NDAs. It is available from thirteen suppliers. Additional details are available on the BUTALBITAL AND ACETAMINOPHEN profile page.

The generic ingredient in BUTALBITAL AND ACETAMINOPHEN is acetaminophen; butalbital. There are sixty-six drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the acetaminophen; butalbital profile page.

Summary for NDA: 205120

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 205120

Ingredient-typeBarbiturates

Suppliers and Packaging for NDA: 205120

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BUTALBITAL AND ACETAMINOPHEN
acetaminophen; butalbital
TABLET;ORAL 205120 ANDA County Line Pharmaceuticals, LLC 43199-053 43199-053-01 100 TABLET in 1 BOTTLE (43199-053-01)
BUTALBITAL AND ACETAMINOPHEN
acetaminophen; butalbital
TABLET;ORAL 205120 ANDA Alvogen, Inc. 47781-535 47781-535-01 100 TABLET in 1 BOTTLE (47781-535-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength325MG;50MG
Approval Date:Oct 30, 2015TE:AARLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
US Department of Justice
Chinese Patent Office
McKesson
Covington
McKinsey
AstraZeneca
Harvard Business School
QuintilesIMS
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot